(Q39113464)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

title

Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

idiopathic pulmonary fibrosis

29 March 2020

main subject

phase II clinical trial

0 references

0 references

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

4

Vincent Cottin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

8

Fernando J Martinez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

13

Wim Wuyts

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

11

Athol U Wells

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

author name string

Ganesh Raghu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Kevin K Brown

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Harold R Collard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Kevin F Gibson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Robert J Kaner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Paul W Noble

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Jin Woo Song

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Timothy P M Whelan

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Emmanuel Moreau

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Scott D Patterson

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Victoria Smith

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Selina Bayly

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Jason W Chien

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Qi Gong

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Jenny J Zhang

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Thomas G O'Riordan

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

publication date

7 December 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

The Lancet. Respiratory medicine

29 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

page(s)

22-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

29 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

Scraping fibrosis: expressway to the core of fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

Hypoxia-inducible factor signaling in the development of kidney fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

Animal models of fibrotic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

Lysyl oxidase: from basic science to future cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

Transglutaminase 2 and its role in pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930421-0

7 January 2021

10.1016/S2213-2600(16)30421-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27939076%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference